Experimental pill helps patients shed 12 per cent of body weight

Eli Lilly says its experimental GLP-1 pill helped patients lose 12.4 per cent of their body weight after 72 weeks in a late-stage study.

Unlike injectable obesity drugs, which are peptides designed to mimic the appetite-controlling GLP-1 hormone, orforglipron is a small molecule pill that is…